Key result
ILRs detect subclinical AF in ~35% of at-risk older adults but overall burden remains low.
Why the study?
As new rhythm monitoring technologies emerge, subclinical AF poses a challenge to health care systems, but the pathological characteristics and natural history of this condition in at-risk patients are largely unknown.
Population
590 individuals ≥70 years with risk factors and no AF history undergoing loop recorder monitoring
Design
Prospective cohort substudy of the LOOP study
Authors
Loading...
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“More than 30% of patients with risk factors will have AF detected if continuous monitoring is applied, but the AF burden is low and AF progression is limited.”
“AF lasting ≥24h was preceded with shorter episodes in 85% of cases”
“The data gathered and presented thus far as part of the LOOP study are valuable in helping clinicians understand what to expect in older, asymptomatic patients with risk factors for stroke who start some form of long-term arrhythmia monitoring (whether self-motivated or on the advice of a physician). Chances are good that AF will be detected within several years in these patients, as it was in 35% of study subjects monitored with an ILR.”
Low-burden subclinical AF by ILR should not yet change practice; leaves open optimal thresholds for intervention or anticoagulation.
Observational (n=590)
Yes
In at-risk older adults, subclinical AF detected by implantable loop recorders is highly prevalent (35%) but typically presents with a very low burden, limited progression, and minimal symptoms.
Diederichsen et al. (2019) conducted an observational in Subclinical atrial fibrillation (n=590). Implantable loop recorder monitoring was evaluated on Atrial fibrillation (AF) burden (cumulative duration of AF episodes ≥6 minutes divided by total monitoring time). Implantable loop recorder monitoring detected subclinical atrial fibrillation in 35% of at-risk older adults, though the median AF burden was low at 0.13% of monitoring time and progression was limited.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: